Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 4 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings or view top-rated stocks.

10 Wall Street research analysts have issued 1 year target prices for Fresenius Medical Care AG & Co. KGaA's shares. Their FMS share price forecasts range from $11.70 to $51.80. On average, they predict the company's stock price to reach $28.20 in the next twelve months. This suggests a possible upside of 32.6% from the stock's current price.
View analysts price targets for FMS or view top-rated stocks among Wall Street analysts.

Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 at the start of the year. Since then, FMS shares have increased by 30.1% and is now trading at $21.26.
View the best growth stocks for 2023 here.

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 3,370,000 shares, an increase of 74.6% from the February 28th total of 1,930,000 shares. Based on an average trading volume of 932,100 shares, the short-interest ratio is currently 3.6 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our FMS earnings forecast.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) posted its earnings results on Tuesday, February, 21st. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.22. The business had revenue of $5.10 billion for the quarter, compared to analysts' expectations of $4.85 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 5.80% and a net margin of 3.46%.

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Investors of record on Monday, May 16th will be paid a dividend of $0.7093 per share on Friday, May 27th. This represents a yield of 3.4%. The ex-dividend date of this dividend is Friday, May 13th.
Read our dividend analysis for FMS.

ETFs with the largest weight of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) stock in their portfolio include Invesco International Dividend Achievers ETF (PID), Cultivar ETF (CVAR), Pacer Global Cash Cows Dividend ETF (GCOW) and Pacer Trendpilot European Index ETF (PTEU).Avantis Responsible International Equity ETF (AVSD) and

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 2.38%. The dividend payout ratio is 40.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 32.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FMS stock can currently be purchased for approximately $21.26.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $12.48 billion and generates $20.44 billion in revenue each year. The company earns $709.50 million in net income (profit) each year or $1.20 on an earnings per share basis.

The company employs 1,235 workers across the globe.

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.